Moschner Matthew 4
4 · COGNEX CORP · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Cognex (CGNX) CEO Matthew Moschner Receives Awards, Sells 1,600 Shares
What Happened
- Matthew Moschner, Cognex Corporation’s President & CEO and a director, reported receiving equity awards and converting derivatives into shares. The filing shows grants/awards totaling 115,672 derivative units (two awards of 58,744 and 56,928 units) reported on Feb 17, 2026, plus the conversion/exercise of 5,085 derivative units into common shares on Feb 18, 2026. To satisfy tax withholding on vested restricted stock units, 1,600 shares were disposed (withheld) at $56.72 per share, totaling $90,752. The awards and conversions were recorded at $0 per share (typical for restricted stock units or stock-settled awards).
Key Details
- Transaction dates: Awards reported Feb 17, 2026; conversion/exercise and tax withholding occurred Feb 18, 2026. Filing date: Feb 19, 2026.
- Specific moves: Grants (A) — 58,744 and 56,928 derivative units; Exercise/Conversion (M) — 5,085 shares; Tax withholding (F) — 1,600 shares sold/withheld at $56.72 ($90,752).
- Shares owned after transaction: Not specified in the items you provided (check the full Form 4 for total holdings).
- Notable footnotes: Withholding of 1,600 shares was to satisfy tax obligations on RSUs that vested (routine tax withholding). Footnotes indicate the awards are restricted stock units (each RSU converts to one share) and describe standard vesting schedules and option vesting timing.
- Timeliness: Filing was submitted on Feb 19, 2026 for transactions in mid-February 2026; no late-filing flag was indicated in the supplied details.
Context
- These transactions are largely awards/vesting and a conversion of derivative awards, not open-market purchases or discretionary sales. The 1,600-share disposition was a routine tax-withholding event tied to vested RSUs rather than a market sale for investment reasons. The exercise/conversion recorded at $0 suggests settlement of RSUs or stock-settled awards rather than a cash exercise of an option.
Insider Transaction Report
Form 4
COGNEX CORPCGNX
Moschner Matthew
DirectorCEO & President
Transactions
- Exercise/Conversion
Common Stock
2026-02-18+5,085→ 13,447 total - Tax Payment
Common Stock
[F1]2026-02-18$56.72/sh−1,600$90,752→ 11,847 total - Award
Non-Qualified Stock Option (right to buy)
[F2]2026-02-17+58,744→ 58,744 totalExercise: $57.09From: 2027-02-17Exp: 2036-02-17→ Common Stock (58,744 underlying) - Exercise/Conversion
Restricted Stock Unit
[F3][F4]2026-02-18−5,085→ 20,339 totalExercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (5,085 underlying) - Award
Restricted Stock Unit
[F3][F5]2026-02-17+56,928→ 56,928 totalExercise: $0.00From: 2027-02-17Exp: 2029-02-17→ Common Stock (56,928 underlying)
Holdings
- 279,070
Non-Qualified Stock Option (right to buy)
Exercise: $27.99From: 2029-05-05Exp: 2035-05-05→ Common Stock (279,070 underlying) - 76,924
Non-Qualified Stock Option (right to buy)
Exercise: $32.78From: 2029-02-21Exp: 2035-02-21→ Common Stock (76,924 underlying) - 68,823
Non-Qualified Stock Option (right to buy)
Exercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (68,823 underlying) - 58,260
Non-Qualified Stock Option (right to buy)
Exercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (58,260 underlying) - 4,000
Non-Qualified Stock Option (right to buy)
Exercise: $40.71From: 2019-11-19Exp: 2028-11-19→ Common Stock (4,000 underlying) - 7,000
Non-Qualified Stock Option (right to buy)
Exercise: $42.84From: 2021-10-31Exp: 2028-10-31→ Common Stock (7,000 underlying) - 37,832
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (37,832 underlying) - 35,639
Non-Qualified Stock Option (right to buy)
Exercise: $47.95From: 2026-08-04Exp: 2032-08-04→ Common Stock (35,639 underlying) - 47,962
Non-Qualified Stock Option (right to buy)
Exercise: $50.01From: 2027-08-07Exp: 2033-08-07→ Common Stock (47,962 underlying) - 4,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (4,000 underlying) - 9,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.97From: 2020-10-30Exp: 2029-10-30→ Common Stock (9,000 underlying) - 1,600
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (1,600 underlying) - 8,426
Non-Qualified Stock Option (right to buy)
Exercise: $86.38From: 2025-08-09Exp: 2031-08-09→ Common Stock (8,426 underlying) - 3,495
Restricted Stock Unit
Exercise: $0.00From: 2024-02-21Exp: 2026-02-21→ Common Stock (3,495 underlying) - 4,999
Restricted Stock Unit
Exercise: $0.00From: 2024-08-07Exp: 2026-08-07→ Common Stock (4,999 underlying) - 8,113
Restricted Stock Unit
Exercise: $0.00From: 2025-02-20Exp: 2027-02-20→ Common Stock (8,113 underlying)
Footnotes (5)
- [F1]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 18, 2026 and are reported herein.
- [F2]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 17, 2026).
- [F3]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- [F4]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.
- [F5]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 17, 2026), respectively.
Signature
Matthew Moschner|2026-02-19